MedPath
NMPA Approval

Rimegepant Sulfate Orally Disintegrating Tablets

国药准字HJ20240004

January 23, 2024

Drug Information

硫酸瑞美吉泮口崩片

乐泰可

片剂

75mg(按 C₂₈H₂₈F₂N₆O₃计)

化学药品

January 23, 2024

January 22, 2029

Company Information

Applicant Company

PFIZER INC.

66 Hudson Boulevard East, New York, NY 10001 United States of America

Manufacturing Company

Frankland Road, Blagrove, Swindon, Wiltshire SN5 8RU UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸瑞美吉泮口崩片 - NMPA 批准文号 | MedPath